SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-006817
Filing Date
2018-03-08
Accepted
2018-03-08 16:38:54
Documents
1
Period of Report
2018-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8036
  Complete submission text file 0000899243-18-006817.txt   9640
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAVELIN PHARMACEUTICALS, INC. 125 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Tulipano Stephen J (Reporting) CIK: 0001360548 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36332 | Film No.: 18676996